Nellix
Palo Alto
About Nellix
Nellix has developed an original device designed to address and expand the indication for the less invasive treatment of Abdominal Aortic Aneurysms (AAAs) and Thoratic Aortic Aneurysms (TAAs). Enabling the treatment of all aneurysms with a low profiles delivery system and innovative endograft, the Nellix device has the potential to double the market size for Endovascular Aneurysms Repair (EVAR), which exceeded $800M in 2008 with a 16% CAGR (Med Tech Insight).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $8.8M
- Funding stage: M&A
- Last round: Series C (Mar 2008)
- Website: nellix.com
- Phone: +1 650-213-8700
Industries & Categories
Biotechnology, Health Care, Medical Device
Canonical: https://fsome.com/organization/nellix-2738198 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.